Speech-Language Pathologists in Quincy, PA Accepting Medicare
2 Speech-Language Pathologists found. Showing 1 - 2
 Mr. Joseph Louis Garcia, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6596 Orphanage Road, Quincy, PA 17247 Phone: 717-762-7178 Fax: 717-762-7178 |
 Danielle N. Lucido, M.A., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6596 Orphanage Road, Quincy, PA 17247 Phone: 717-749-3151 |
News Archive
Researchers shed light on biological mechanism underlying link between height and cognition
Reports from several studies have identified a link between height and general cognitive ability, or intelligence, but the mechanisms underlying this association are not well known. Researchers from the University of Helsinki, University of California San Diego and Boston University found that this association is mediated by cortical surface area.
NICE Appraisal Committee reconfirms clinical effectiveness of ILUVIEN
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Appraisal Committee of the United Kingdom's National Institute for Health and Care Excellence has issued a positive Appraisal Consultation Document on ILUVIEN for the treatment of pseudophakic patients with chronic diabetic macular edema considered insufficiently responsive to available therapies.
Report proposes near-universal health coverage system allowing individuals, small businesses to purchase insurance through private plans or new Medicare-like option
A national health insurance "connector" program that allows individuals and small businesses to buy public and private health coverage could provide insurance for up to 44 million uninsured U.S. residents, according to an article by the Commonwealth Fund published in the May/June issue of the journal Health Affairs, CQ HealthBeat reports.
FDA OKs TWi Pharmaceuticals' tentative ANDA for Guanfacine Hydrochloride Extended Release Tablets
TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.
› Verified 5 days ago